Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Psychiatric Research

• Publication date

  2004-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.JPSYCHIRES.2003.10.004PMID 15003430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

  2003cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Sustained Response to Open-Label Venlafaxine in Drug-Resistant Major Depression

  2001cited by this paper
• Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues

  2001cited by this paper
• Low Serum Cholesterol Concentration and Risk of Suicide

  2001cited by this paper
• Antidepressants in long‐term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors

  2000cited by this paper
• The Design, Implementation, and Acceptance of a Primary Care-Based Intervention to Prevent Depression Relapse

  2000cited by this paper
• Low serum cholesterol levels and depressive state in human dock visitors

  2000cited by this paper
• Managed care cost-containment strategies and their impact on physician prescribing and treatment of depression. Based on a presentation by Robert K. Schreter, MD.

  2000cited by this paper
• Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission.

  2000cited by this paper
• A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.

  1999cited by this paper
• Long-term nature of depression.

  1999cited by this paper
• Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 years.

  1999cited by this paper
• Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.

  1999cited by this paper
• Introduction: defining remission in patients treated with antidepressants.

  1999cited by this paper
• Association of low serum total cholesterol with major depression and suicide

  1999cited by this paper
• Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.

  1999cited by this paper
• Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity

  1998cited by this paper
• Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.

  1998cited by this paper
• Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression

  1997cited by this paper
• Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.

  1997cited by this paper
• An Open Study of Sertraline in Acute and Continuation Treatment of Depressed Out-Patients

  1997cited by this paper
• Efficacy of venlafaxine in depressive illness in general practice

  1997cited by this paper
• Efficacy of venlafaxine and placebo during long‐term treatment of depression: a pooled analysis of relapse rates

  1996cited by this paper
• An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients.

  1996cited by this paper
• The Safety and Tolerability of Venlafaxine Hydrochloride: Analysis of the Clinical Trials Database

  1996cited by this paper
• Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis.

  1995cited by this paper
• Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.

  1995cited by this paper
• Recognition, management, and outcomes of depression in primary care.

  1995cited by this paper
• Venlafaxine for treatment-resistant unipolar depression.

  1994cited by this paper
• Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients

  1994cited by this paper
• Placebo‐controlled efficacy of antidepressants in continuation treatment

  1994cited by this paper
• Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.

  1994cited by this paper
• The long-term treatment of depression.

  1994cited by this paper
• Long-term treatment of depression

  1994cited by this paper
• Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders.

  1993cited by this paper
• Guidelines for treating depressive illness with antidepressants

  1993cited by this paper
• Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

  1993cited by this paper
• The place of obsessive compulsive disorder in the diagnostic hierarchy

  1992cited by this paper
• Sertraline in the Prevention of Depression

  1992cited by this paper
• Long-term treatment of depression.

  1991cited by this paper
• CONTINUATION AND MAINTENANCE THERAPY WITH ANTIDEPRESSIVE AGENTS : META-ANALYSIS OF RESEARCH(II). AUTHOR'S REPLY

  1991cited by this paper
• Methodologic issues in maintenance therapy clinical trials.

  1991cited by this paper
• Continuation and maintenance therapy with antidepressive agents

  1990cited by this paper
• Continuation drug therapy for major depressive episodes: how long should it be maintained?

  1986cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Comparison of antidepressant deprescribing strategies in individuals with clinically remitted depression: a systematic review and network meta-analysis.

  2026cites this paper
• Strategies for antidepressant medications in the maintenance phase: A systematic review and network Meta-analysis.

  2025cites this paper
• When to stop medication in unipolar depression: A systematic review and a meta-analysis of randomized controlled trials.

  2023cites this paper
• Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis

  2022cites this paper
• Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis

  2020cites this paper
• Effects of antidepressant medicines on preventing relapse of unipolar depression: a pooled analysis of parametric survival curves

  2020cites this paper
• Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: Results of a 6‐month follow‐up

  2019cites this paper
• Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study

  2019cites this paper
• Effect of HPMC K 4 M Polymeron Gastroretentive Floating Tablets of Venlafaxine Hydrochloride

  2018cites this paper
• Differing antidepressant maintenance methodologies.

  2017cites this paper
• Enantioselective disposition of venlafaxine and its metabolite o-desmethylvenlafaxine in rats

  2017cites this paper
• An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder.

  2015cites this paper
• A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan

  2015cites this paper
• Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial.

  2015cites this paper
• The effect of personality traits on the intention to adopt M-Learning

  2014cites this paper
• Desvenlafaxine for the treatment of major depressive disorder

  2014cites this paper
• Shared decision-making after implementation of the Chronic Care Model (CCM) - an evaluative approach

  2014cites this paper
• A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.

  2014cites this paper
• Development and evaluation of gastroretentive floating tablets of an antidepressant drug by thermoplastic granulation technique

  2014cites this paper
• Formulation Design, Optimization and Pharmacodynamic Evaluation of Sustained Release Mucoadhesive Microcapsules of Venlafaxine HCl

  2014cites this paper
• Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis

  2013cites this paper
• L21 Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents

  2013cites this paper
• Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

  2013cites this paper
• Clinical Handbook for the Management of Mood Disorders

  2013cites this paper
• Liquid chromatography tandem mass spectrometry method for the simultaneous stereoselective determination of venlafaxine and its major metabolite, O-desmethylvenlafaxine, in human plasma.

  2013cites this paper
• Formulation and Evaluation of Controlled Release Floating Tablets of Venlafaxine HCl Using Almond Gum

  2013cites this paper
• THE SERTRALINE VERSUS ELECTRICAL CURRENT THERAPY FOR TREATING DEPRESSION CLINICAL STUDY (SELECT‐TDCS): RESULTS OF THE CROSSOVER AND FOLLOW‐UP PHASES

  2013cites this paper
• Continuation transcranial direct current stimulation for the prevention of relapse in major depression.

  2013cites this paper
• Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial.

  2013cites this paper
• FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF VENLAFAXINE HYDROCHLORIDE

  2012cites this paper
• Remission from depression

  2012cites this paper
• ORIGINAL RESEARCH Economic Evaulation Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder

  2012cites this paper
• Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.

  2012cites this paper
• Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.

  2012cites this paper
• Drug Class Review: Second-Generation Antidepressants

  2011cites this paper
• Depression in adults: drug and physical treatments.

  2011cites this paper
• Blue Again: Perturbational Effects of Antidepressants Suggest Monoaminergic Homeostasis in Major Depression

  2011influential citation
• Development and characterization of gastroretentive mucoadhesive tablets of venlafaxine hydrochloride

  2010cites this paper
• PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder

  2010cites this paper
• Interactive associations of race and comorbidity in medication treatment and outcomes of Medicaid enrolled patients with major depressive disorder

  2010cites this paper
• Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder: Results of a Randomized Trial

  2010cites this paper
• Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders

  2010cites this paper
• Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.

  2009cites this paper
• Agomelatine:Antidepressant with a New Mechanism of Action

  2009cites this paper
• Clinical Studies on the Efficacy of Agomelatine on Depressive Symptoms

  2009influential citation
• The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression

  2009cites this paper
• Evidence Synthesis for Determining the Responsiveness of Depression Questionnaires and Optimal Treatment Duration for Antidepressant Medications

  2009cites this paper
• Interventions for preventing relapse and recurrence after the first episode of a depressive disorder in young people

  2008cites this paper
• The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.

  2008cites this paper
• Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.

  2008cites this paper
• Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.

  2008cites this paper
• Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians

  2008influential citation
• Early intervention for depressive disorders in young people : the opportunity and the ( lack of ) evidence

  2007cites this paper
• Long-Term Treatment of Depression with Antidepressants: A Systematic Narrative Review

  2007cites this paper
• Depression in adults: drug and physical treatments.

  2007cites this paper
• Preventing recurrent depression: long-term treatment for major depressive disorder.

  2007cites this paper
• Current situation of long-term treatment of depression.

  2007cites this paper
• INTERVENTIONS INTERVENTIONS IN MILD TO MODERATE, OR SE- VERE DEPRESSION

  2007cites this paper
• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.

  2007cites this paper
• Impact of Study Design on the Results of Continuation Studies of Antidepressants

  2007cites this paper
• Early intervention for depressive disorders in young people: the opportunity and the (lack of) evidence

  2007cites this paper
• Long-Term, Open-Label Venlafaxine Extended-Release Treatment in Children and Adolescents with Major Depressive Disorder

  2007cites this paper
• Limitations of contemporary antidepressants: tolerability.

  2007cites this paper
• Management of depression relapse: re-initiation of duloxetine treatment or dose increase.

  2006cites this paper
• Preventing Relapse and Recurrence of Depression: A Brief Review of Therapeutic Options

  2006cites this paper
• Beyond Remission: Rationale and Design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Selegiline Transdermal System in the Prevention of Relapse of Major Depressive Disorder: A 52-Week, Double-blind, Placebo-Substitution, Parallel-Group Clinical Trial

  2006cites this paper
• Treatment of anxiety disorders with venlafaxine XR

  2006cites this paper
• IPM volume 23 issue 3 Cover and Front matter

  2006cites this paper
• Efectividad y seguridad de la venlafaxina XR en el tratamiento de la depresión mayor

  2005cites this paper
• Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug.

  2005cites this paper
• Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition

  2005cites this paper
• The medical management of depression.

  2005cites this paper
• Remission from depression : a review of venlafaxine clinical and economic evidence.

  2005cites this paper
• Duloxetine and Venlafaxine-XR in the Treatment of Major Depressive Disorder: A Meta-Analysis of Randomized Clinical Trials

  2005cites this paper
• Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?

  2004cites this paper